C vs CGEM · P/E 16, rev $85.22B vs $830.3M cap
Citigroup Inc. (C) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
C currently screens at market cap $214.73B and trailing P/E 15.5. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the C and CGEM stock pages for the full models.
Not investment advice.